Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Clinical Trial Launches to Test Bundibugyo Virus Treatments
July 2026
Patient enrolment has begun in the PARTNERS clinical trial evaluating potential antiviral treatments for Bundibugyo virus disease in the DRC.
Read more
23 Jan 2025
15% of Children Aged Under 3 Years Receive Invalid Vaccine Doses
Research reveals that 15% of children aged 0–35 months in the USA received at least one invalid vaccine dose between 2011–2020.
21 Jan 2025
Increased ME/CFS Risk in Adults Post-COVID-19
The ongoing RECOVER-Adult study reveals that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops significantly more frequently following SARS-CoV-2 infection.
19 Jan 2025
Procalcitonin Guidance Fails to Shorten Antibiotic Use in Children
Using a procalcitonin-guided algorithm does not significantly reduce duration of IV antibiotic treatment in children with bacterial infections.
17 Jan 2025
New Antibodies Offer Hope for Malaria Vaccine Complementation
A recent study has identified a previously unknown antibody target on the Plasmodium falciparum sporozoite surface.
15 Jan 2025
Gut Microbiome Signatures of Different Diets Revealed
A new multinational study has uncovered how omnivore, vegetarian, and vegan diets affect the human gut microbiome
13 Jan 2025
HMPV Cases Surge in Northern Hemisphere
Human metapneumovirus (hMPV) is making headlines as one of the key respiratory pathogens driving a surge in acute respiratory infections.
11 Jan 2025
NGS Tools Show Promise in Predicting AMR in Pneumococci
Both Pathogenwatch and AREScloud demonstrated strong performance in predicting antimicrobial resistance in Streptococcus pneumoniae isolates.
7 Jan 2025
Characteristics of Human Cases of Avian Influenza A(H5N1)
A recent analysis of human cases of the highly pathogenic avian influenza A(H5N1) virus in the USA has provided new insights into the virus’s effects.
Loading posts...
« Previous
1
…
31
32
33
34
35
…
50
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View